Veerhealth Care Ltd

Veerhealth Care's historical performance shows net sales growth from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25, but profitability has fluctuated, with profit after tax declining from 1.58 Cr in Mar'23 to 0.39 Cr in Mar'25. Total assets increased significantly, while cash flow from operating activities dropped to 0.00 Cr in Mar'25.

Veerhealth Care's latest Q2 FY26 results show a decline in net sales by 11.36% quarter-over-quarter and 22.72% year-on-year, despite a slight increase in net profit. Overall, while there are some improvements in profitability metrics, the significant revenue drop and ongoing challenges suggest a difficult operational landscape.

Veerhealth Care's historical performance shows increasing net sales and total assets, rising from INR 5.98 crore in 2019 to INR 16.67 crore in 2025, but faced challenges with declining profitability and cash flow management. Operating profit decreased to INR 1.68 crore in 2025, while profit before tax fell to INR 0.51 crore.

Veerhealth Care has experienced revenue growth from 9.63 Cr in Mar'22 to 16.67 Cr in Mar'25, but profitability metrics have fluctuated, with profit before tax declining to 0.51 Cr in Mar'25 from 1.28 Cr in Mar'24. Total assets increased to 33.77 Cr in Mar'25, while cash flow from operating activities dropped to 0.00 Cr in Mar'25.

As of 07-Nov, Veerhealth Care Ltd's stock price is at 17.88, down 1.22% and has underperformed with a total decline of 4.94% over the last three days. The stock is facing challenges with reduced investor participation and has significantly lagged behind the broader market, which has gained over the past year.

Veerhealth Care has shown growth in net sales and total assets from Mar'22 to Mar'25, with net sales increasing from 9.63 Cr to 16.67 Cr. However, profitability and cash flow have fluctuated, with operating profit improving but profit after tax declining significantly by Mar'25.

As of 03-Nov, Veerhealth Care Ltd's stock price is at 18.71, showing a short-term gain but a longer-term decline of 5.07% year-to-date. Despite outperforming the sector today, investor participation has decreased significantly, indicating reduced interest.

As of 17-Oct, Veerhealth Care Ltd's stock price is declining at 17.90, down 2.61%, and has underperformed its sector. Despite increased investor participation, the stock has shown negative returns over various periods and is struggling compared to the overall market's positive performance.

Veerhealth Care has experienced growth in net sales and total assets from Mar'22 to Mar'25, but profitability has been inconsistent, with fluctuations in profit before tax and a decline in cash flow from operating activities. The company relies on financing for liquidity despite positive sales growth.

Veerhealth Care has shown strong growth in net sales and total assets from Mar'22 to Mar'25, with net sales increasing from 9.63 Cr to 16.67 Cr. However, profitability has fluctuated, with profit before tax declining from 1.28 Cr in Mar'24 to 0.51 Cr in Mar'25.

As of 06-Oct, Veerhealth Care Ltd's stock price is at 19.25, having increased by 1.85% recently. While it has outperformed the Sensex in the short term, it has underperformed year-to-date and shows declining investor participation, raising concerns about future growth.

As of 25-Sep, Veerhealth Care Ltd's stock price is at 18.18, having increased by 1.45% today, despite a significant decline of 15.87% over the past month. The stock has shown strong long-term returns but faces concerns regarding liquidity due to a sharp drop in investor participation.